Concentric Capital Strategies’s Merck MRK Stock Holding History

Concentric Capital Strategies’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$927K	Buy	7,217 +3,725	+107%	+$436K	0.05%	233
2026 Q1	$420K	Buy	3,492 +1,059	+44%	+$122K	0.04%	233
2025 Q4	$256K	Sell	2,433 -114,797	-98%	-$10.8M	0.01%	245
2025 Q3	$9.84M	Buy	117,230 +114,556	+4,284%	+$9.44M	0.44%	65
2025 Q2	$212K	Buy	+2,674	New	+$213K	0.01%	263
2025 Q1	–	Sell	-2,596	Closed	-$258K	–	253
2024 Q4	$258K	Sell	2,596 -10,527	-80%	-$1.09M	0.01%	242
2024 Q3	$1.49M	Buy	13,123 +5,439	+71%	+$646K	0.06%	223
2024 Q2	$951K	Sell	7,684 -58,954	-88%	-$7.59M	0.05%	251
2024 Q1	$8.79M	Buy	+66,638	New	+$8.21M	0.49%	56
2023 Q4	–	Sell	-4,072	Closed	-$419K	–	291
2023 Q3	$419K	Buy	+4,072	New	+$439K	0.04%	180

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Concentric Capital Strategies's MRK Position: Q2 2026 in Review

Concentric Capital Strategies increased its Merck (MRK) stake by 107% in Q2 2026, buying an estimated $436K and bringing the position to 7,217 shares worth $927K. The position accounts for 0.05% of the portfolio, ranked #233.

Concentric Capital Strategies first reported a position in MRK in Q3 2023 and has held it in 10 quarters since. The position peaked at $9.84M in Q3 2025. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Concentric Capital Strategies held 7,217 shares of Merck worth $927K as of Q2 2026.
Concentric Capital Strategies bought 3,725 Merck shares in Q2 2026, an estimated $436K.
Merck made up 0.05% of Concentric Capital Strategies's portfolio in Q2 2026, its #233 holding.
Concentric Capital Strategies first reported a position in Merck in Q3 2023 and has held it in 10 quarters since.
Concentric Capital Strategies's Merck position peaked at $9.84M in Q3 2025.
3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.